EMA/PE/0000258095 - paediatric investigation plan
levodopa
carbidopa monohydrate
PIPHuman
Latvian is available via eTranslation, the European Commission's machine translation service.
Translate to Latvian | Important information about machine translation
Key facts
- Active substance
- levodopa
- carbidopa monohydrate
- Therapeutic area
- Nervous system disorders
- Decision number
- EMA/PE/0000258095
- PIP number
- EMA/PE/0000258095
- Pharmaceutical form(s)
- Modified release capsule
- Condition(s) / indication(s)
- Treatment of Parkinson's disease
- Route(s) of administration
- Oral use
- Contact for public enquiries
Zambon S.p.A.
E-mail: marzia.michieletto@zambongroup.com
Tel.: +39 0266524256- Decision type
- W: decision granting a waiver in all age groups for all conditions or indications
- Decision date
- Compliance check done
- Nē